|
|
|
|
| LEADER |
01000cas a22002652 4500 |
| 001 |
DOAJ000092932 |
| 003 |
DE-627 |
| 005 |
20240105064436.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
230225c20189999xx u| |o 0 |0eng c |
| 022 |
|
|
|a 20402066
|
| 035 |
|
|
|a (DE-627)DOAJ000092932
|
| 035 |
|
|
|a (DE-599)DOAJa6cbfe5b4f4c450bbfa556d64f99a9f2
|
| 035 |
|
|
|a (DE-627)37597847X
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Antiviral Chemistry & Chemotherapy
|
| 264 |
3 |
1 |
|b SAGE Publishing
|c 2018-
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 540 |
|
|
|a CC BY
|
| 540 |
|
|
|a CC BY-NC
|
| 650 |
|
4 |
|a antiviral drugs
|
| 650 |
|
4 |
|a pharmacology
|
| 650 |
|
4 |
|a chemotherapy
|
| 650 |
|
4 |
|a Infectious and parasitic diseases
|
| 650 |
|
4 |
|a RC109-216
|
| 856 |
4 |
0 |
|u https://doaj.org/toc/2040-2066
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://us.sagepub.com/en-us/nam/gold-open-access-article-processing-charge-waivers
|x Verlag
|z kostenfrei
|
| 856 |
4 |
0 |
|u http://journals.sagepub.com/home/avc
|x Verlag
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://journals.sagepub.com/author-instructions/avc
|x Verlag
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://journals.sagepub.com/aims-scope/avc
|x Verlag
|z kostenfrei
|
| 912 |
|
|
|a GBV_DOAJ
|
| 951 |
|
|
|a JT
|
